Sort
10,829 grants matching “car t”
Optimizing CAR T Cell Therapy
$379,293Bruce R. Blazar · University Of Minnesota · P01 · FY2016 · CA
Optimizing CAR T Cell Therapy
$379,257Bruce R. Blazar · University Of Minnesota · P01 · FY2017 · CA
Optimizing CAR T Cell Therapy
$379,224Bruce R. Blazar · University Of Minnesota · P01 · FY2018 · CA
The B7x pathways in the tumor microenvironment
$379,050Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Improving Technician Training in Battery Technology
$378,987Robert E Wechsler · Florida State College At Jacksonville · · FY2022 · EDU
Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma
$378,675Paolo Strati · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · CA
Quantifying the attentional template
$378,611Joy Jia Geng · University Of California At Davis · R01 · FY2018 · MH
Tumor microenvironment-dependent therapy resistance
$378,600Shahab Asgharzadeh · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Prevention of adenovirus pathogenesis through downregulation of the apical adenovirus receptor
$378,540Abimbola Olayinka Kolawole · Wright State University · R01 · FY2021 · AI
Age-Related Meibomian Gland Dysfunction
$378,525James V Jester · University Of California-Irvine · R01 · FY2014 · EY
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
$378,416Han Xiao · Rice University · R35 · FY2023 · GM
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
$378,416Han Xiao · Rice University · R35 · FY2021 · GM
Development and Applications of Unnatural Organisms with a 21 Amino Acid Genetic Code
$378,416Han Xiao · Rice University · R35 · FY2022 · GM
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$378,389Mark S Berger · Actinium Pharmaceuticals, Inc. · R42 · FY2020 · CA
Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AML
$378,249Jeffrey S Miller · University Of Minnesota · P01 · FY2024 · CA
Smartphone-based diagnostic for HIV self-testing
$378,111Jacqueline Linnes · Purdue University · R61 · FY2019 · AI
SBIR Phase II: Revenue Management in a Dynamic and Stochastic Network Environment
$378,101Georgia Mourtzinou · Dynamic Ideas, Llc · · FY2001 · TIP
Effects of circadian desynchrony during adolescent alcohol exposure on immediate and long-term risk of alcohol addiction: role of sleep homeostasis and stress signaling
$378,095Danielle Gulick · University Of South Florida · R01 · FY2023 · AA
Linking Process-Induced Properties to Thermoplastic-Matrix Woven-Fabric Composites Performance
$378,000James Sherwood · University Of Massachusetts Lowell · · FY2005 · ENG
The B7x pathways in the tumor microenvironment
$378,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2022 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2025 · CA
Neural mechanisms mediating visual search
$377,953Robert Desimone · Massachusetts Institute Of Technology · R01 · FY2013 · EY
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
$377,457Aimee S Payne · Columbia University Health Sciences · R01 · FY2025 · AR
Mechanisms of Enterovirus Entry
$377,425Susan Hafenstein · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · AI